Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multifactorial Inheritance | 10 | 2024 | 1387 | 1.800 |
Why?
|
Cardiomyopathy, Dilated | 4 | 2024 | 829 | 1.280 |
Why?
|
Coronary Artery Disease | 16 | 2024 | 6403 | 1.280 |
Why?
|
Biological Specimen Banks | 4 | 2024 | 783 | 1.170 |
Why?
|
Genome-Wide Association Study | 29 | 2024 | 12690 | 0.860 |
Why?
|
Heart Failure | 11 | 2023 | 11670 | 0.690 |
Why?
|
Genetic Predisposition to Disease | 22 | 2024 | 17904 | 0.610 |
Why?
|
Ventricular Remodeling | 2 | 2022 | 1267 | 0.570 |
Why?
|
Referral and Consultation | 3 | 2015 | 3600 | 0.550 |
Why?
|
Cardiovascular Diseases | 11 | 2024 | 15501 | 0.550 |
Why?
|
Cardiomyopathies | 3 | 2023 | 1964 | 0.540 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2022 | 1310 | 0.530 |
Why?
|
Quality Assurance, Health Care | 2 | 2015 | 2169 | 0.490 |
Why?
|
Myocardial Infarction | 7 | 2023 | 11461 | 0.440 |
Why?
|
Cardiology | 2 | 2017 | 1656 | 0.420 |
Why?
|
Disease | 4 | 2024 | 672 | 0.370 |
Why?
|
Equipment Contamination | 1 | 2011 | 182 | 0.350 |
Why?
|
Models, Genetic | 1 | 2020 | 3442 | 0.340 |
Why?
|
Bradycardia | 1 | 2011 | 299 | 0.340 |
Why?
|
Disease Management | 1 | 2020 | 2508 | 0.330 |
Why?
|
Menopause, Premature | 2 | 2020 | 124 | 0.320 |
Why?
|
Acute Coronary Syndrome | 2 | 2010 | 2190 | 0.280 |
Why?
|
Polymorphism, Single Nucleotide | 12 | 2024 | 15936 | 0.270 |
Why?
|
Ethics, Medical | 1 | 2011 | 783 | 0.270 |
Why?
|
Pacemaker, Artificial | 1 | 2011 | 807 | 0.260 |
Why?
|
Hypertension | 4 | 2022 | 8540 | 0.260 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2373 | 0.250 |
Why?
|
Gene Expression Profiling | 2 | 2022 | 9420 | 0.240 |
Why?
|
Blood Pressure | 6 | 2020 | 8481 | 0.240 |
Why?
|
Humans | 65 | 2024 | 761572 | 0.240 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2011 | 1725 | 0.230 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2024 | 56 | 0.220 |
Why?
|
Vascular Diseases | 2 | 2023 | 1161 | 0.210 |
Why?
|
Heredity | 2 | 2020 | 148 | 0.210 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7391 | 0.210 |
Why?
|
Electronic Health Records | 1 | 2020 | 4811 | 0.210 |
Why?
|
Risk | 4 | 2020 | 9610 | 0.200 |
Why?
|
Atrial Function, Left | 1 | 2023 | 185 | 0.200 |
Why?
|
Muscle Proteins | 2 | 2023 | 1154 | 0.180 |
Why?
|
Veterans | 3 | 2023 | 2649 | 0.170 |
Why?
|
Risk Assessment | 7 | 2024 | 23996 | 0.170 |
Why?
|
Chromosomes, Human, X | 1 | 2021 | 321 | 0.160 |
Why?
|
Photoplethysmography | 1 | 2019 | 60 | 0.160 |
Why?
|
Heart Ventricles | 2 | 2022 | 3807 | 0.160 |
Why?
|
Middle Aged | 26 | 2023 | 220920 | 0.160 |
Why?
|
Mendelian Randomization Analysis | 5 | 2024 | 1007 | 0.160 |
Why?
|
Prescriptions | 1 | 2021 | 386 | 0.160 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2019 | 277 | 0.160 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2010 | 2751 | 0.150 |
Why?
|
Activin Receptors, Type I | 1 | 2018 | 134 | 0.150 |
Why?
|
Ventricular Function, Left | 2 | 2022 | 3879 | 0.150 |
Why?
|
Pathology, Molecular | 1 | 2021 | 328 | 0.150 |
Why?
|
Heart | 3 | 2022 | 4404 | 0.150 |
Why?
|
Oxidoreductases | 1 | 2020 | 413 | 0.150 |
Why?
|
Pedigree | 2 | 2023 | 4542 | 0.150 |
Why?
|
Atrial Fibrillation | 3 | 2022 | 5127 | 0.140 |
Why?
|
Peripheral Arterial Disease | 2 | 2019 | 1273 | 0.140 |
Why?
|
Primary Prevention | 2 | 2023 | 1186 | 0.140 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2022 | 395 | 0.140 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 588 | 0.140 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2023 | 696 | 0.140 |
Why?
|
Genetic Loci | 3 | 2021 | 2632 | 0.130 |
Why?
|
Lipoprotein(a) | 1 | 2021 | 480 | 0.130 |
Why?
|
Fingers | 1 | 2019 | 507 | 0.130 |
Why?
|
Male | 25 | 2024 | 360842 | 0.130 |
Why?
|
Cohort Studies | 6 | 2023 | 41493 | 0.130 |
Why?
|
Female | 30 | 2024 | 392686 | 0.130 |
Why?
|
Menopause | 2 | 2020 | 1646 | 0.120 |
Why?
|
Healthcare Disparities | 1 | 2011 | 3358 | 0.120 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2019 | 513 | 0.120 |
Why?
|
Blood Proteins | 1 | 2020 | 1173 | 0.120 |
Why?
|
Risk Factors | 15 | 2023 | 74213 | 0.120 |
Why?
|
Albuminuria | 1 | 2018 | 657 | 0.120 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2017 | 705 | 0.120 |
Why?
|
Mitochondrial Proteins | 1 | 2020 | 976 | 0.110 |
Why?
|
Death, Sudden, Cardiac | 1 | 2022 | 1555 | 0.110 |
Why?
|
Fatty Liver | 1 | 2020 | 790 | 0.110 |
Why?
|
Genetic Variation | 4 | 2024 | 6567 | 0.110 |
Why?
|
Metabolic Diseases | 1 | 2018 | 683 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2022 | 2118 | 0.100 |
Why?
|
Equipment Reuse | 1 | 2011 | 45 | 0.100 |
Why?
|
Dyslipidemias | 1 | 2019 | 868 | 0.100 |
Why?
|
Myocardium | 2 | 2024 | 4725 | 0.090 |
Why?
|
Osteoarthritis | 1 | 2019 | 1063 | 0.090 |
Why?
|
Aged | 14 | 2022 | 169310 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2024 | 3548 | 0.090 |
Why?
|
Pre-Eclampsia | 1 | 2020 | 1231 | 0.090 |
Why?
|
Sterilization | 1 | 2011 | 133 | 0.090 |
Why?
|
Mutation, Missense | 1 | 2020 | 2571 | 0.090 |
Why?
|
Mutation | 3 | 2022 | 30054 | 0.090 |
Why?
|
Case-Control Studies | 7 | 2024 | 22176 | 0.090 |
Why?
|
Genetic Testing | 2 | 2021 | 3537 | 0.090 |
Why?
|
Phenotype | 7 | 2023 | 16592 | 0.090 |
Why?
|
Proteomics | 2 | 2023 | 3848 | 0.090 |
Why?
|
Michigan | 1 | 2011 | 339 | 0.090 |
Why?
|
Stroke Volume | 2 | 2022 | 5496 | 0.090 |
Why?
|
Predictive Value of Tests | 3 | 2023 | 15266 | 0.090 |
Why?
|
Lipids | 1 | 2021 | 3341 | 0.090 |
Why?
|
Liver Cirrhosis | 1 | 2020 | 1935 | 0.080 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2019 | 1081 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2022 | 12148 | 0.080 |
Why?
|
Body Mass Index | 3 | 2022 | 12954 | 0.080 |
Why?
|
Alcohol Drinking | 1 | 2022 | 4028 | 0.080 |
Why?
|
Quantitative Trait Loci | 3 | 2024 | 2116 | 0.080 |
Why?
|
Fellowships and Scholarships | 1 | 2017 | 1117 | 0.080 |
Why?
|
Nitric Oxide | 1 | 2017 | 2135 | 0.080 |
Why?
|
Body Weight | 1 | 2019 | 4618 | 0.080 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2010 | 284 | 0.070 |
Why?
|
Genome, Human | 1 | 2021 | 4425 | 0.070 |
Why?
|
Epigenomics | 2 | 2024 | 943 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3245 | 0.070 |
Why?
|
Angioplasty | 1 | 2010 | 355 | 0.070 |
Why?
|
Overweight | 1 | 2019 | 2417 | 0.070 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2010 | 577 | 0.070 |
Why?
|
Databases, Factual | 2 | 2020 | 7967 | 0.070 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4740 | 0.070 |
Why?
|
Incidence | 6 | 2021 | 21355 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2023 | 3408 | 0.070 |
Why?
|
Sweden | 2 | 2020 | 1379 | 0.070 |
Why?
|
Coronary Disease | 2 | 2019 | 5914 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2019 | 1866 | 0.070 |
Why?
|
Mass Screening | 1 | 2022 | 5428 | 0.060 |
Why?
|
Drug Interactions | 1 | 2010 | 1416 | 0.060 |
Why?
|
Cholesterol, LDL | 3 | 2020 | 2382 | 0.060 |
Why?
|
Survival Rate | 2 | 2021 | 12725 | 0.060 |
Why?
|
Angina, Unstable | 1 | 2009 | 888 | 0.060 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2023 | 1050 | 0.060 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7827 | 0.060 |
Why?
|
Exercise | 1 | 2020 | 5890 | 0.050 |
Why?
|
Proteins | 1 | 2018 | 6032 | 0.050 |
Why?
|
Sleep | 1 | 2019 | 4768 | 0.050 |
Why?
|
Gene Frequency | 2 | 2021 | 3606 | 0.050 |
Why?
|
Adult | 10 | 2021 | 221203 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5336 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8711 | 0.050 |
Why?
|
Subtilisins | 1 | 2021 | 81 | 0.050 |
Why?
|
Time Factors | 4 | 2020 | 39970 | 0.050 |
Why?
|
Quality Indicators, Health Care | 1 | 2011 | 1792 | 0.050 |
Why?
|
Subcutaneous Tissue | 1 | 2021 | 132 | 0.040 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 2020 | 64 | 0.040 |
Why?
|
Genetic Association Studies | 2 | 2021 | 2735 | 0.040 |
Why?
|
Obesity | 2 | 2019 | 12947 | 0.040 |
Why?
|
Signal Transduction | 2 | 2024 | 23447 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2020 | 360 | 0.040 |
Why?
|
Aspirin | 1 | 2010 | 3133 | 0.040 |
Why?
|
Factor V | 1 | 2019 | 167 | 0.040 |
Why?
|
Medication Adherence | 1 | 2010 | 2176 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58986 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39107 | 0.040 |
Why?
|
Carrier Proteins | 2 | 2022 | 4937 | 0.040 |
Why?
|
Eye Proteins | 1 | 2021 | 633 | 0.040 |
Why?
|
Ovariectomy | 1 | 2019 | 614 | 0.040 |
Why?
|
Medical History Taking | 1 | 2021 | 774 | 0.040 |
Why?
|
Receptors, LDL | 1 | 2019 | 488 | 0.030 |
Why?
|
Thrombosis | 1 | 2010 | 2942 | 0.030 |
Why?
|
Adolescent | 2 | 2022 | 88324 | 0.030 |
Why?
|
Genotype | 2 | 2021 | 12990 | 0.030 |
Why?
|
Respiratory Hypersensitivity | 1 | 2018 | 273 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2021 | 610 | 0.030 |
Why?
|
Logistic Models | 1 | 2011 | 13255 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2024 | 1668 | 0.030 |
Why?
|
Arthroplasty, Replacement | 1 | 2019 | 310 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2254 | 0.030 |
Why?
|
Homozygote | 1 | 2020 | 1776 | 0.030 |
Why?
|
Stroke | 1 | 2017 | 9758 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2021 | 1475 | 0.030 |
Why?
|
Haplotypes | 1 | 2021 | 2713 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2019 | 771 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2023 | 14607 | 0.030 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2020 | 1135 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2020 | 1134 | 0.030 |
Why?
|
Hormone Replacement Therapy | 1 | 2019 | 751 | 0.030 |
Why?
|
Ubiquitin | 1 | 2019 | 839 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2015 | 80646 | 0.030 |
Why?
|
Research Design | 1 | 2009 | 6180 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2021 | 4615 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2023 | 3769 | 0.030 |
Why?
|
Fasting | 1 | 2019 | 1603 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36429 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2019 | 1814 | 0.030 |
Why?
|
United States | 2 | 2022 | 72335 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2009 | 20099 | 0.020 |
Why?
|
Triglycerides | 1 | 2019 | 2461 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2018 | 1742 | 0.020 |
Why?
|
Animals | 2 | 2020 | 168467 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29629 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2898 | 0.020 |
Why?
|
Health Status | 1 | 2022 | 4077 | 0.020 |
Why?
|
Population Surveillance | 1 | 2019 | 2598 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6864 | 0.020 |
Why?
|
DNA | 1 | 2022 | 7213 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9646 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4415 | 0.020 |
Why?
|
Pregnancy | 2 | 2020 | 29876 | 0.020 |
Why?
|
Heart Diseases | 1 | 2021 | 2781 | 0.020 |
Why?
|
Self Report | 1 | 2019 | 3725 | 0.020 |
Why?
|
Gene Expression | 1 | 2019 | 7581 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 54426 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5821 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12463 | 0.020 |
Why?
|
Young Adult | 2 | 2023 | 59255 | 0.020 |
Why?
|
Chronic Disease | 1 | 2019 | 9319 | 0.010 |
Why?
|
Blood Glucose | 1 | 2019 | 6391 | 0.010 |
Why?
|
Liver | 1 | 2020 | 7529 | 0.010 |
Why?
|
Age Factors | 1 | 2021 | 18398 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 11904 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2009 | 64684 | 0.010 |
Why?
|
Child | 2 | 2021 | 80156 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22172 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15843 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 26127 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 26198 | 0.010 |
Why?
|
Algorithms | 1 | 2018 | 14032 | 0.010 |
Why?
|
Mice | 1 | 2019 | 81533 | 0.010 |
Why?
|